Genscript Biotech Corporation (HKG:1548)

Genscript Biotech Revenue

Genscript Biotech had revenue of $404.22M USD in the half year ending June 30, 2026, with 41.75% growth. This brings the company's total for the last twelve months to $844.97M, up 2.04% year-over-year. In the year 2025, Genscript Biotech had annual revenue of $959.53M with 61.40% growth. That makes Genscript Biotech the 8,443rd largest company in the world by revenue and 516th in Hong Kong.

• Revenue (ttm): $844.97M
• Revenue Growth: +2.04%
• P/S Ratio: 11.27
• Revenue / Employee: $137.73K
• Employees: 6,135
• Market Cap: 77.13B HKD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Life-Science Services and Products 522.13M 50.5%
• Biologics Development Services 388.69M 37.6%
• Operation Unit 66.07M 6.4%
• Industrial Synthetic Biology Products 57.95M 5.6%

By Geography

Chart

• Mainland China 476.08M 49.6%
• The United States of America 293.00M 30.5%
• Europe 104.55M 10.9%
• Asia Pacific (Excluding Mainland China) 58.97M 6.1%
• Others 26.94M 2.8%

Fiscal year ended Dec 31, 2025 See the full Genscript Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	959.53M	365.04M	61.40%
Dec 31, 2024	594.49M	34.01M	6.07%
Dec 31, 2023	560.48M	-65.22M	-10.42%
Dec 31, 2022	625.70M	135.60M	27.67%
Dec 31, 2021	490.10M	99.25M	25.39%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 3, 2026

Data Sources Report a data error